X

Trial Profile

Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX- Colorectal Cancer (CRC) Trial

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 09 Feb 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Avelumab (Primary) ; Cetuximab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
Indications Colorectal cancer; Liver metastases
Focus Therapeutic Use
Acronyms AVETUX
Sponsors AIO Studien gGmbH

Most Recent Events

28 Sep 2022 Status changed from active, no longer recruiting to completed.
14 Oct 2021 Planned End Date changed from 1 Aug 2021 to 1 Jul 2022.
02 Oct 2020 Planned primary completion date changed from 1 May 2020 to 1 Jul 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com